메뉴 건너뛰기




Volumn 20, Issue 10, 2011, Pages 1063-1071

Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (PAI-1) promoter polymorphism on premature atherosclerosis in SLE patients

Author keywords

atherosclerosis; fibrinolytic parameters; PAI 1; PAI 1 polymorphism; systemic lupus erythematosus (SLE); tPA

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; FIBRINOGEN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISONE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80052888574     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311404911     Document Type: Article
Times cited : (15)

References (38)
  • 1
    • 0348182230 scopus 로고
    • Morbidity in systemic lupus erythematosus
    • Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol. 1987 ; 14: 223-226
    • (1987) J Rheumatol , vol.14 , pp. 223-226
    • Gladman, D.D.1    Urowitz, M.B.2
  • 4
    • 26244442446 scopus 로고    scopus 로고
    • Atherogenesis and autoimmune disease: The model of lupus
    • DOI 10.1191/0961203305lu2201oa, Heart, Rheumatism and Autoimmunity
    • Bruce IN. Atherogenesis and autoimmune disease: the model of lupus. Lupus. 2005 ; 14: 687-690 (Pubitemid 41413292)
    • (2005) Lupus , vol.14 , Issue.9 , pp. 687-690
    • Bruce, I.N.1
  • 5
    • 0028832052 scopus 로고
    • Association of fibrinolytic parameters with early atherosclerosis: The ARIC Study
    • Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study. Circulation. 1995 ; 91: 284-290
    • (1995) Circulation , vol.91 , pp. 284-290
    • Salomaa, V.1    Stinson, V.2    Kark, J.D.3    Folsom, A.R.4    Davis, C.E.5    Wu, K.K.6
  • 6
    • 0027274074 scopus 로고
    • Endogenous tissue-type plasminogen activator and risk of myocardial infarction
    • DOI 10.1016/0140-6736(93)90998-V
    • Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993 ; 34: 1165-1168 (Pubitemid 23137110)
    • (1993) Lancet , vol.341 , Issue.8854 , pp. 1165-1168
    • Ridker, P.M.1    Vaughan, D.E.2    Stampfer, M.J.3    Manson, J.E.4    Hennekens, C.H.5
  • 7
    • 0027311245 scopus 로고
    • The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells
    • Dawson SJ, Wiman B, Hamsten A, Green F, Humpries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993 ; 268: 10739-10745 (Pubitemid 23162248)
    • (1993) Journal of Biological Chemistry , vol.268 , Issue.15 , pp. 10739-10745
    • Dawson, S.J.1    Wiman, B.2    Hamsten, A.3    Green, F.4    Humphries, S.5    Henney, A.M.6
  • 8
    • 0028901713 scopus 로고
    • Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
    • Eriksson P, Kallin B, van't Hooft FM, Båvenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 1995 ; 92: 1851-1855
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 1851-1855
    • Eriksson, P.1    Kallin, B.2    Van'T Hooft, F.M.3    Båvenholm, P.4    Hamsten, A.5
  • 9
    • 0028882653 scopus 로고
    • Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes
    • Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost. 1995 ; 74: 1032-1034
    • (1995) Thromb Haemost , vol.74 , pp. 1032-1034
    • Mansfield, M.W.1    Stickland, M.H.2    Grant, P.J.3
  • 10
    • 0031853098 scopus 로고    scopus 로고
    • The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes
    • DOI 10.1016/S0021-9150(97)00191-3, PII S0021915097001913
    • Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis. 1998 ; 136: 109-114 (Pubitemid 28341447)
    • (1998) Atherosclerosis , vol.136 , Issue.1 , pp. 109-114
    • Iwai, N.1    Shimoike, H.2    Nakamura, Y.3    Tamaki, S.4    Kinoshita, M.5
  • 11
    • 0031229830 scopus 로고    scopus 로고
    • Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
    • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
    • (1997) Arthritis Rheum , vol.40 , pp. 1725-1725
    • Hochberg, M.C.1
  • 13
    • 0034974761 scopus 로고    scopus 로고
    • Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease
    • DOI 10.1016/S0021-9150(00)00705-X, PII S002191500000705X
    • Viitanen L, Pihlajamäki J, Halonen P, et al. Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease. Atherosclerosis. 2001 ; 157: 57-64 (Pubitemid 32539354)
    • (2001) Atherosclerosis , vol.157 , Issue.1 , pp. 57-64
    • Viitanen, L.1    Pihlajamaki, J.2    Halonen, P.3    Lehtonen, M.4    Kareinen, A.5    Lehto, S.6    Laakso, M.7
  • 14
    • 0032752441 scopus 로고    scopus 로고
    • Classification and definition of major flares in SLE clinical trials
    • DOI 10.1191/096120399680411281
    • Petri M, Buyon J, Kim M. Classification and definition of major flares in SLE clinical trials. Lupus. 1999 ; 8: 685-691 (Pubitemid 29520536)
    • (1999) Lupus , vol.8 , Issue.8 , pp. 685-691
    • Petri, M.1    Buyon, J.2    Kim, M.3
  • 17
    • 28544441683 scopus 로고    scopus 로고
    • 'Not only...but also': Factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
    • DOI 10.1093/rheumatology/kei142
    • Bruce IN. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology. 2005 ; 44: 1492-1502 (Pubitemid 41742464)
    • (2005) Rheumatology , vol.44 , Issue.12 , pp. 1492-1502
    • Bruce, I.N.1
  • 22
    • 47349107461 scopus 로고    scopus 로고
    • Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity
    • Kiani AN, Magder L, Petri M. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity. J Rheumatol. 2008 ; 35: 1300-1306 (Pubitemid 352000774)
    • (2008) Journal of Rheumatology , vol.35 , Issue.7 , pp. 1300-1306
    • Kiani, A.N.1    Magder, L.2    Petri, M.3
  • 23
    • 73449120372 scopus 로고    scopus 로고
    • Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review
    • Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010 ; 69: 20-28
    • (2010) Ann Rheum Dis , vol.69 , pp. 20-28
    • Ruiz-Irastorza, G.1    Ramos-Casals, M.2    Brito-Zeron, P.3    Khamashta, M.A.4
  • 26
    • 0026459695 scopus 로고
    • Risk factors for coronary artery disease in patients with systemic lupus erythematosus
    • Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992 ; 93: 513-519
    • (1992) Am J Med , vol.93 , pp. 513-519
    • Petri, M.1    Perez-Gutthann, S.2    Spence, D.3    Hochberg, M.C.4
  • 28
    • 0027360661 scopus 로고
    • Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: A 7-year follow-up
    • Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7-year follow-up. Circulation. 1993 ; 88: 2030-2034 (Pubitemid 23326079)
    • (1993) Circulation , vol.88 , Issue.5 , pp. 2030-2034
    • Jansson, J.-H.1    Olofsson, B.-O.2    Nilsson, T.K.3
  • 29
    • 0029124975 scopus 로고
    • The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study
    • Ye S, Green FR, Scarabin PY, Nicaud V, et al. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost. 1995 ; 74: 837-841
    • (1995) Thromb Haemost , vol.74 , pp. 837-841
    • Ye, S.1    Green, F.R.2    Scarabin, P.Y.3    Nicaud, V.4
  • 30
    • 0032599948 scopus 로고    scopus 로고
    • Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels
    • Matsubara Y, Murata M, Isshiki I, et al. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels. Int J Hematol. 1999 ; 69: 43-47
    • (1999) Int J Hematol , vol.69 , pp. 43-47
    • Matsubara, Y.1    Murata, M.2    Isshiki, I.3
  • 31
    • 0037976711 scopus 로고    scopus 로고
    • Insulin resistance, plasma PAI-1 levels and PAI-1 gene polymorphism in healthy centenarians
    • Barbieri M, Rizzo MR, Ragno E, et al. Insulin resistance, plasma PAI-1 levels and PAI-1 gene polymorphism in healthy centenarians. J Endocrinol Invest. 2002 ; 25 (10 Suppl). 110-112
    • (2002) J Endocrinol Invest , vol.25 , Issue.10 SUPPL. , pp. 110-112
    • Barbieri, M.1    Rizzo, M.R.2    Ragno, E.3
  • 32
    • 35548948085 scopus 로고    scopus 로고
    • Interferon-α promotes abnormal vasculogenesis in lupus: A potential pathway for premature atherosclerosis
    • DOI 10.1182/blood-2007-05-089086
    • Denny MF, Thacker S, Mehta H, et al. Interferon α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood. 2007 ; 110: 2907-2915 (Pubitemid 350006944)
    • (2007) Blood , vol.110 , Issue.8 , pp. 2907-2915
    • Denny, M.F.1    Thacker, S.2    Mehta, H.3    Somers, E.C.4    Dodick, T.5    Barrat, F.J.6    McCune, W.J.7    Kaplan, M.J.8
  • 33
    • 0031016432 scopus 로고    scopus 로고
    • Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men
    • Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation. 1997 ; 95: 59-62 (Pubitemid 27029943)
    • (1997) Circulation , vol.95 , Issue.1 , pp. 59-62
    • Ridker, P.M.1    Hennekens, C.H.2    Lindpaintner, K.3    Stampfer, M.J.4    Miletich, J.P.5
  • 34
    • 56349095296 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease
    • Onalan O, Balta G, Oto A, et al. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis. 2008 ; 26 (3). 211-217
    • (2008) J Thromb Thrombolysis , vol.26 , Issue.3 , pp. 211-217
    • Onalan, O.1    Balta, G.2    Oto, A.3
  • 35
    • 25444451853 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus
    • DOI 10.1196/annals.1361.068
    • Somers EC, Marder W, Kaplan MJ, Brook RD, McCune WJ. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus. Ann N Y Acad Sci. 2005 ; 1051: 271-280 (Pubitemid 41362756)
    • (2005) Annals of the New York Academy of Sciences , vol.1051 , pp. 271-280
    • Somers, E.C.1    Marder, W.2    Kaplan, M.J.3    Brook, R.D.4    McCune, W.J.5
  • 36
    • 9544247771 scopus 로고    scopus 로고
    • Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis
    • Salazar-Paramo M, Garcia dela Torre I, Fritzler MJ, Loyau S, Angles-Cano E. Antibodies to fibrin bound tissue type plasminogen activato in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis. Lupus. 1996 ; 5 (4). 275-278 (Pubitemid 26306235)
    • (1996) Lupus , vol.5 , Issue.4 , pp. 275-278
    • Salazar-Paramo, M.1    Garcia De La Torre, I.2    Fritzler, M.J.3    Loyau, S.4    Angles-Cano, E.5
  • 37
    • 0036182186 scopus 로고    scopus 로고
    • Genetic variations in plasminogen activator inhibitor-1 gene and β fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect
    • Gong R, Liu Z, Chen Z, Li L. Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 ; 19: 1-5 (Pubitemid 34151595)
    • (2002) Chinese Journal of Medical Genetics , vol.19 , Issue.1 , pp. 1-5
    • Gong, R.1    Liu, Z.2    Chen, Z.3    Li, L.4
  • 38
    • 0035069831 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients
    • DOI 10.1046/j.1523-1755.2001.0590041520.x
    • Moon Wang AY, Poon P, Lai FM, et al. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Kidney Int. 2001 ; 59: 1520-1528 (Pubitemid 32281243)
    • (2001) Kidney International , vol.59 , Issue.4 , pp. 1520-1528
    • Wang, A.Y.M.1    Poon, P.2    Lai, F.M.3    Yu, L.4    Choi, P.C.L.5    Siu Fai Lui6    Li, P.K.T.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.